Doxorubicin—An Agent with Multiple Mechanisms of Anticancer Activity

Doxorubicin (DOX) constitutes the major constituent of anti-cancer treatment regimens currently in clinical use. However, the precise mechanisms of DOX’s action are not fully understood. Emerging evidence points to the pleiotropic anticancer activity of DOX, including its contribution to DNA damage,...

Descripción completa

Detalles Bibliográficos
Autores principales: Kciuk, Mateusz, Gielecińska, Adrianna, Mujwar, Somdutt, Kołat, Damian, Kałuzińska-Kołat, Żaneta, Celik, Ismail, Kontek, Renata
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9954613/
https://www.ncbi.nlm.nih.gov/pubmed/36831326
http://dx.doi.org/10.3390/cells12040659

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9954613/
https://www.ncbi.nlm.nih.gov/pubmed/36831326
http://dx.doi.org/10.3390/cells12040659

Ejemplares similares